The Oral Solid Dosage Contract Manufacturing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of oral solid dosage contract manufacturing has been experiencing robust growth recently. It is projected to increase from $39.39 billion in 2024 to $42.51 billion in 2025, with a compound annual growth rate (CAGR) of 7.9%.
The market size for oral solid dosage contract manufacturing is projected to reach $56.89 billion by the year 2029. The compound annual growth rate (CAGR) for the same period is expected to be 7.6%.
Download Your Free Sample of the 2025 Oral Solid Dosage Contract Manufacturing Market Report and Uncover Key Trends Now!The drivers in the oral solid dosage contract manufacturing market are:
• Rise in global population
• Increasing prevalence of chronic diseases
• Enhanced focus on research and development
• Robust growth in the contract manufacturing market
The oral solid dosage contract manufacturing market covered in this report is segmented –
1) By Product Type: Tablets, Capsules, Powders, Granules, Other Product Types
2) By Service: Drug Product Development, Fill Finish Product Manufacturing, API Manufacturing, Packaging And Labelling, Other Applications
3) By Therapeutic Area: Oncology, Cardiovascular Diseases, Metabolic Disorders, Neurological Disorders, infectious Diseases, Gastrointestinal Diseases, Other Therapeutic Areas
4) By End User: Large Size Companies, Medium And Small Size Companies
The trends in the oral solid dosage contract manufacturing market are:
• Increasing outsourcing by pharmaceutical companies is a notable trend in the market.
• There is a rising focus on advancements in drug delivery technology.
• The integration of 3D printing techniques is another emerging trend.
• The field is observing advancements in controlled-release technologies.
The major players in the oral solid dosage contract manufacturing market are:
• Pfizer Inc.
Asia-Pacific was the largest region in the oral solid dosage contract manufacturing market in 2023